head and neck tumor parotid gland tumor, thyroid tumor
Conditions
Interventions
Intravenous infusion of acetaminophen every 6 hours after head and neck tumor surgery
Performed until 2 days after surgery Total 9-10 cycles
D010149
postoperative pain
Sponsors
Endo Kazuhira
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: head and neck tumor Surgery case under general anesthesia 20 years of age or older Performance Status (ECOG) is 0 or 1 After obtaining informed consent for participation in the clinical research, the patient's voluntary written consent has been obtained
Exclusion criteria
Exclusion criteria: Patients with a history of allergy to acetaminophen in the past Patients with aspirin asthma Patients with liver dysfunction and thrombocytopenia Patients who indicated their intention to refuse to participate before regular administration of Acerio Patients who are judged to be unsuitable as subjects by the judgment of a doctor
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Pain VAS score (on the day of surgery, postoperative days 1 and 2) | — |
Secondary
| Measure | Time frame |
|---|---|
| Length of hospital stay, postoperative oral intake (average of staple food and side dish), number of times of use of NSAIDs until postoperative day 2, adverse events | — |
Contacts
Public ContactKazuhira Endo
Kanazawa University Hospital
Outcome results
None listed